Halal Drugs Become An Choice, Help Patients Undergo Treatment More Comfortably

Illustration of the manufacture of halal drugs. (doc. Etana)

JAKARTA - For many patients in Indonesia, the treatment of a disease is not only a matter of seeking healing, but also about calm while living it.

As awareness of the importance of halal products increases, the need for halal certified medicines is now a major concern. Not only for food or cosmetics, halal guarantees in drugs are also considered important so that patients feel safe and comfortable while undergoing therapy.

In recent years, the pharmaceutical industry in Indonesia has started to respond to this need by presenting medical products that are not only effective, but also in accordance with halal principles.

This is also believed by Wuragil Kartika Sari, Marketing Manager of Therapeutic Business Unit Etana, explaining that the presence of halal anti-oagulan drugs has an important meaning for the wider community.

"Halal guarantees are now an important and crucial factor, especially because the majority of Indonesians are Muslims. We understand that even though anticoagulan products are life-saving, having a halal option will help patients get good therapy as well as peace of mind in religious beliefs," said Wuragil.

Therefore, Etana officially obtained a halal certificate from the Food, Medicine and Cosmetic Studies Institute of the Indonesian Ulema Council (LPPOM MUI) for drugs such as the Sodium Enoxaparin, which is used for anti-coagulan therapy.

This drug is used to prevent and treat blood vessel blockage disorders due to thromboemboly.

Enoxaparin Sodium products are developed and produced locally by Etana using basic ingredients from sheep (ovine) sources. These drugs are commonly prescribed for patients with the risk of blood clots, such as those with heart disease, postoperative patients, and those undergoing therapy are analyzed.

He added that the halal certification process carried out by LPPOM MUI includes a thorough examination of the production chain, from raw materials to the final stages to ensure that there are no elements or non-halal contamination in each process.

"This one drug is developed and produced locally, as a form of our commitment in presenting high quality therapy and guaranteed halalness. We hope this step strengthens the patient's trust and sense of security and health workers without reducing the quality or effectiveness of treatment," he added.

The halal certification was officially received since August 2025, an important milestone for Etana in expanding patient access to anticoagulant therapy which is not only medically effective, but also in accordance with religious principles.

As an anticoagulan therapy, Enoxaparin Sodium is used to prevent and overcome blood clots in various medical conditions ranging from postoperative patients to people with acute heart attacks.

Its presence as a halal certified local product is expected to provide an alternative for calmer and more convincing treatment for patients in Indonesia.

"We hope that Enoxaparin Sodium Etana will not only be a safe and reliable choice for patients, but also strengthen the sovereign and global competitive national pharmaceutical industry," concluded Wuragil.